Jennifer  Baker, MD
Accepting new patients

Jennifer Baker, MD

  • Surgical Oncology|
  • Breast Surgery
Revlon Breast Center | 100 Medical Plaza, Suite 310, Los Angeles, CA 90095


Download Dr. Baker's complete CV.

Dr Baker is a board-certified and fellowship-trained breast surgical oncologist and Assistant Professor of surgery at University of California Los Angeles.  Her clinical interests include oncoplastic breast surgery including aesthetic flat closures; skin and nipple sparing mastectomy; targeted axillary surgery; inflammatory breast cancer; high risk patients; BRCA mutation carriers; and breast cancer in young women.

Dr Baker's research focuses on new surgical approaches to treating breast cancer and epigenetic markers to predict outcomes and alter treatment recommendations.  She is an invited lecturer to national and international meetings and her research is regularly published in high impact journals.  

She also serves as the UCLA cancer liaison physician for the American College of Surgeons Commission on Cancer and is a member of the UCLA Cancer Services Committee. She is the director of UCLA’s Society of Surgical Oncology (SSO)-accredited breast surgery fellowship. She also serves on national committees for the SSO, American Society of Breast Surgeons, and is on the National Comprehensive Cancer Network (NCCN) breast cancer screening and diagnosis guidelines panel.

Dr Baker completed her general surgery training at University of California, San Diego and her fellowship in breast surgical oncology at Memorial Sloan Kettering Cancer Center in New York City. She is board-certified in general surgery and is a Fellow of the American College of Surgeons.





Breast Surgical Oncology, Memorial Sloan-Kettering Cancer Center, 2018


General Surgery, UC San Diego School of Medicine, 2017


General Surgery, UC San Diego School of Medicine, 2011


MD, University of Iowa College of Medicine, 2010


Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center


Surgical Management of Breast Cancer - Jennifer Baker, MD | UCLAMDChat



  • Aesthetic Flat Closure
  • Axillary Management after neoadjuvant chemotherapy and node-positive breast cancer
  • Oncoplastic breast surgery
  • Breast Cancer in Young Women
  • Epigenetic and gene pathways in breast cancer


  1. Toesca A, Snagalli C, Maisonneuve P, Massari G, Girardi A, Baker JL, Lissigini G, Invento A, Farante G, Corso G, Rietjens M, Peradze N, Gottardi A, Magnoni F, Bottiglieri L, Laxxeroni M, Montagna E, Orecchia R, Galimberti V, Intra M, Sacchini V, Veronesi P.  Robotic nipple-sparing mastectomy versus conventional open technique for breast cancer: an open-label, phase 3, single centre, randomized, controlled trial. Ann Surg. June 2021

  2. Baker JL, Dizon D, Strega E, Thompson CK, Lee MK, Attai DJ.  "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey. Ann Surg Oncol 2021 Jan 3. PMID 33393205

  3. Baker JL, Hegde J, Thompson CK, Lee MK, DiNome ML.  Locoregional Management of Inflammatory Breast Cancer. Current Breast Cancer Reports 12:326-335 (2020).

  4. Angarita S, Ye L, Runger D, Hadaya J, Baker JL, Dawson N, Thompson CK, Lee MK, Attai DJ, DiNome ML.  Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery.  Ann Surg Oncology. Online first Oct 22, 2020. PMID 33084993

  5. Toesca A, Invento A, Massari G, Baker JL, et al. Update on the Feasibility and Progress on Robotic Breast Surgery. Ann Surg Oncol. 2019. 10.1245/s10434-019-07590-7
  6. Baker JL, Muhsen S, Zabor E, Stempel M, Gemignani M. Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed? Ann Surg Oncol. 2019; 26:336-342
  7. Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera DR, Wallace AM. Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy. Ann Surg Oncol. 2015; 22 Suppl 3: 559-65. PMID 26275779
  8. Baker JL, Schwab RB, Wallace AM, Madlensky L. Breast Cancer in a RAD51D Mutation Carrier: Case Report and Review of the Literature. Clinical Breast Cancer. 2015; 15 (1):71-5. PMID 25445424
  9. Baker JL, Minya P, Messer K, Tokin CA, Hoh CK, Vera DR, Wallace AM. Comparison of [99mTc]Tilmanocept and Filtered-[99mTc]sulfur colloid for identification of SLNs in Breast Cancer Patients. Ann Surg Oncol. 2015; 22(1):40-5. PMID 25069859
  10. Weiss A, Tran V, Baker J, Farnaz H, Wallace AM, Chang D, Ojeda-Fournier H, Blair SL. Increased Likelihood of Mastectomy in Human Epidermal Growth Factor Receptor 2-positive Ductal Carcinoma In Situ. Am Surg. 2014 Oct; 80(10):936-9. PMID 25264633


  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • L.A. Care
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.


  • Top Doctors, Los Angeles Magazine, 2023
  • Super Doctors® Southern California Rising Stars 2020-2024
  • Top Doctors, Los Angeles Magazine, 2021-2022
  • Top Doctors, Pasadena Magazine, 2021-2022
  • Dr. Tapan K Chaudhuri Award: Best Paper Breast Cancer Research, Society of Nuclear Medicine and Molecular Imaging Annual Meeting, 2013
  • Graduated Alpha Omega Alpha from University of Iowa Medical School, 2010